61. Inside The New Long COVID GLP-1 Study
About this episode
Dr. Khan interviews Dr. Julia Moore-Vogel about a new study using tirzepatide to treat Long COVID.
Dr Khan interviews Dr. Julia Moore-Vogel, Scripps Researcher and lead scientist of the new study using tirzepatide to treat Long COVID. The study is called LoCITT-T, and it is actively enrolling participants. They discuss the study's design, eligibility criteria, and the potential benefits of the drug. Julia shares her personal experience with long COVID and how it has influenced her work. The conversation also covers the importance of making clinical trials accessible to those with disabilit...
More episodes of Long Covid, MD
- 69. Protecting Our Caregivers
- 68. The NEW Study on Stellate Ganglion Block
- 67. Stellate Ganglion Blocks, Explained by Experts
- 66.How Close Are We to an Approved Long COVID Treatment? | RECOVER-TLC Research Update
- 65. Why Has Your Recovery Stalled?
- Christmas SOS
Explore listener stats, chart rankings, contacts and more on the Long Covid, MD podcast page.